Enjoy complimentary customisation on priority with our Enterprise License!
***1. Executive Summary
***2. Market Landscape
**2.1 Market ecosystem
*Exhibit 01: Parent market
**2.2 Market Characteristics
*Exhibit 02: Market Characteristics
**2.2 Value chain analysis
*2.2.1 Research and development:
*2.2.2 Developers and manufacturers:
*2.2.3 Sales and distribution:
*2.2.4 End-users:
***3. Market Sizing
**3.1 Market definition
*Exhibit 03: Offerings of vendors included in the market definition
**3.2 Market segment analysis
*Exhibit 04: Market segments
**3.3 Market size 2020
**3.4 Market outlook: Forecast for 2020 - 2025
*3.4.1 Estimating growth rates for emerging and high-growth markets
*3.4.2 Estimating growth rates for mature markets
*Exhibit 05: Global - Market size and forecast 2020 - 2025 ($ million)
*Exhibit 06: Global market: Year-over-year growth 2020 - 2025 (%)
***4. Five Forces Analysis
**4.1 Five Forces Summary
*Exhibit 07: Five forces analysis 2020 & 2025
**4.2 Bargaining power of buyers
*Exhibit 08: Bargaining power of buyers
**4.3 Bargaining power of suppliers
*Exhibit 09: Bargaining power of suppliers
**4.4 Threat of new entrants
*Exhibit 10: Threat of new entrants
**4.5 Threat of substitutes
*Exhibit 11: Threat of substitutes
**4.6 Threat of rivalry
*Exhibit 12: Threat of rivalry
**4.7 Market condition
*Exhibit 13: Market condition - Five forces 2020
***5. Market Segmentation by Deployment
*The segments covered in this chapter are:
**5.1 Market segments
*Exhibit 14: Deployment - Market share 2020-2025 (%)
**5.2 Comparison by Deployment
*Exhibit 15: Comparison by Deployment
**5.3 On-premise - Market size and forecast 2020-2025 ($ million)
*Exhibit 16: On-premise - Year-over-year growth 2020-2025 (%)
*Exhibit 17: On-premise - Market size and forecast 2020-2025 ($ million)
**5.4 Cloud - Market size and forecast 2020-2025
*Exhibit 18: Cloud - Market size and forecast 2020-2025 ($ million)
*Exhibit 19: Cloud - Year-over-year growth 2020-2025 (%)
**5.5 Market opportunity by Deployment
*Exhibit 20: Market opportunity by Deployment
***6. Customer landscape
*Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
*Exhibit 21: ?Customer landscape?
***7. Geographic Landscape
*The regions covered in the report are:
*7.1 Geographic segmentation
*Exhibit 22: Market share by geography 2020-2025 (%)
**7.2 Geographic comparison
*Exhibit 23: Geographic comparison
**7.3 North America - Market size and forecast 2020-2025
*Exhibit 24: North America - Market size and forecast 2020-2025 ($ million)
*Exhibit 25: North America - Year-over-year growth 2020-2025 (%)
**7.4 Europe - Market size and forecast 2020-2025
*Exhibit 26: Europe - Market size and forecast 2020-2025 ($ million)
*Exhibit 27: Europe - Year-over-year growth 2020-2025 (%)
**7.5 APAC - Market size and forecast 2020-2025
*Exhibit 28: APAC - Market size and forecast 2020-2025 ($ million)
*Exhibit 29: APAC- Year-over-year growth 2020-2025 (%)
**7.6 MEA - Market size and forecast 2020-2025
*Exhibit 30: MEA - Market size and forecast 2020-2025 ($ million)
*Exhibit 30: MEA - Year-over-year growth 2020-2025 (%)
**7.7 South America - Market size and forecast 2020-2025
*Exhibit 32: South America - Market size and forecast 2020-2025 ($ million)
*Exhibit 33: South America - Year-over-year growth 2020-2025 (%)
**7.8 Key leading countries
*Exhibit 34: Key leading countries
**7.9 Market opportunity by geography
*Exhibit 35: Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends
**8.1 Market drivers
*8.1.1 Increasing number of clinical trials
*8.1.2 Rising government funding and grants to support clinical trials
*8.1.3 Increasing R and D expenditure by pharma-biotech companies
**8.2 Market challenges
*8.2.1 Budget constraints
*8.2.2 Clinical data privacy
*8.2.3 Lack of skilled professionals for operating eTMF systems
*Exhibit 36: Impact of drivers and challenges
**8.3 Market trends
*8.3.1 Rising adoption of Electronic Trial Master File (eTMF) systems in developing countries
*8.3.2 Technological advancements
*8.3.3 Increasing strategic initiatives between vendors
***9. Vendor Landscape
**9.1 Competitive scenario
**9.2 Vendor landscape
*Exhibit 37: Vendor landscape
**9.3 Landscape disruption
*The potential for the disruption of the market landscape was moderate in 2020, and its threat is expected to remain unchanged by 2025.
*Exhibit 38: ?Landscape disruption?
**9.4 Industry risks
*Exhibit 39: Industry risks
***10. Vendor Analysis
**10.1 Vendors covered
*Exhibit 40: Vendors covered
**10.2 Market positioning of vendors
*Exhibit 41: ?Market positioning of vendors?
**10.3 Aurea Corp.
*Exhibit 42: Aurea Corp. - Overview
*Exhibit 43: Aurea Corp. - Business segments
*Exhibit 44: Aurea Corp. - Key offerings
**10.4 IQVIA Holdings Inc.
*Exhibit 45: IQVIA Holdings Inc. - Overview
*Exhibit 46: IQVIA Holdings Inc. - Business segments
*Exhibit 47: IQVIA Holdings Inc.- Key news
*Exhibit 49: IQVIA Holdings Inc. - Key offerings
*Exhibit 50: IQVIA Holdings Inc. - Segment focus
**10.5 Laboratory Corp. of America Holdings
*Exhibit 51: Laboratory Corp. of America Holdings - Overview
*Exhibit 52 Laboratory Corp. of America Holdings - Business segments
*Exhibit 53: Laboratory Corp. of America Holdings - Key news
*Exhibit 54: Laboratory Corp. of America Holdings - Key offerings
*Exhibit 55: Laboratory Corp. of America Holdings - Segment focus
**10.6 MasterControl Inc.
*Exhibit 56: MasterControl Inc. - Overview
*Exhibit 57: MasterControl Inc. - Business segments
*Exhibit 58: MasterControl Inc. - Key offerings
**10.7 Oracle Corp.
*Exhibit 59: Oracle Corp. - Overview
*Exhibit 60: Oracle Corp. - Product and service
*Exhibit 61: Oracle Corp. - Key news
*Exhibit 62: Oracle Corp. - Key offerings
*Exhibit 63: Oracle Corp. - Segment focus
**10.8 Phlexglobal Ltd.
*Exhibit 64: Phlexglobal Ltd. - Overview
*Exhibit 65: Phlexglobal Ltd. - Product and service
*Exhibit 66: Phlexglobal Ltd. - Key offerings
**10.9 SureClinical Inc.
*Exhibit 67: SureClinical Inc. - Overview
*Exhibit 68: SureClinical Inc. - Product and service
*Exhibit 69: SureClinical Inc. - Key offerings
**10.10 TransPerfect Global Inc.
*Exhibit 70: TransPerfect Global Inc. - Overview
*Exhibit 71: TransPerfect Global Inc. - Product and service
*Exhibit 72: TransPerfect Global Inc. - Key news
*Exhibit 73: TransPerfect Global Inc. - Key offerings
**10.11 Veeva Systems Inc.
*Exhibit 74: Veeva Systems Inc. - Overview
*Exhibit 75: Veeva Systems Inc. - Business segments
*Exhibit 76: Veeva Systems Inc. - Key news
*Exhibit 77: Veeva Systems Inc. - Key offerings
*Exhibit 78: Veeva Systems Inc. - Segment focus
**10.12 WIRB Copernicus Group
*Exhibit 79: WIRB Copernicus Group - Overview
*Exhibit 80: WIRB Copernicus Group - Product and service
*Exhibit 81: WIRB Copernicus Group – Key news
*Exhibit 82: WIRB Copernicus Group - Key offerings
***11. Appendix
**11.1 Scope of the report
*11.1.1 ????Market definition
*11.1.2 ????Objectives
*11.1.3 ????Notes and caveats
**11.2 Currency conversion rates for US$
*Exhibit 83: ?Currency conversion rates for US$?
**11.3 Research Methodology
*Exhibit 84: ?Research Methodology
*Exhibit 85: ??Validation techniques employed for market sizing?
*Exhibit 86: ??Information sources
**11.4 List of abbreviations
*Exhibit 87: List of abbreviations
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.